Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
View More Consultancies in This RegionMay 16, 2025
Approximately 5 minutes
Sri Lanka Medical Device Registration: MAH, NMRA Review, and Reference Country Reliance
Sri Lanka Medical Device Registration: MAH, NMRA Review, and Reference Country Reliance
The regulation of medical devices and In Vitro Diagnostics (IVDs) in Sri Lanka is governed by the National Medicines Regulatory Authority (NMRA). To legally place a product on the market, foreign manufacturers must navigate a multi-step, complex registration pathway that necessitates appointing a local representative.
Key Requirements for Market Access
1. Local Marketing Authorization Holder (MAH)
Manufacturers must appoint a local Marketing Authorization Holder (MAH) to manage the regulatory process and serve as the legal entity responsible for the product in Sri Lanka.
2. Registration Process Overview
The overall registration process is lengthy, typically taking approximately 20–24 months to complete, and involves multiple sequential stages:
- Manufacturing Site Registration: This initial stage usually requires 7–8 months for approval.
- Sample Import License: A separate license application for samples, often reviewed and granted within 3–4 months.
- Full Registration Dossier Submission: The complete application is submitted to the NMRA and the Ministry of Health for review.
- Registration Approval and Import License: Granted upon successful final review by the NMRA.
3. NMRA Review Structure
Applications are reviewed by NMRA officers. Higher-risk devices are referred to the Medical Device Evaluation Committee, which meets by specialty (e.g., quarterly for surgery, monthly for anesthesia). The complexity of the review dictates the overall timeline.
Reference Country Reliance (Reliance Pathway)
Sri Lanka utilizes a reliance pathway, recognizing regulatory approvals from established markets to expedite the review process. The NMRA accepts approvals from the following Reference Countries:
- United States
- European Union (EU)
- Canada
- Australia
- United Kingdom
- Japan
Devices that are already registered in one of these recognized markets may qualify for regulatory reliance. This reliance can potentially bypass the need for review by the expert evaluation panel for most device classes. However, Class III (High-Risk) products are typically still subject to review by the Medical Device Evaluation Committee, even with Reference Country approval.
Related Articles
Approximately 5 minutes
Sri Lanka Medical Device Advertising: NMRA Pre-Approval and Content Restrictions
In Sri Lanka, all medical device advertising is strictly regulated by the **NMRA's Advertising Evaluation Sub Committee**. **Prior written approval** from the NMRA is mandatory before any ad can be published or broadcast. Applications are reviewed monthly, and advertisements must be truthful, ethical, and **cannot promote products to the general public for the treatment, prevention, or cure of prescribed diseases or disorders**.
Approximately 5 minutes
Sri Lanka Post-Market Surveillance: NMRA Market Control and MAH Obligations
Post-Market Surveillance (PMS) in Sri Lanka is managed by the **NMRA's Market Control Division** to ensure ongoing safety and quality. The local **Marketing Authorization Holder (MAH)** is responsible for actively reporting all adverse events and quality issues to the NMRA, maintaining distribution records, and assisting with investigations and mandatory product recalls.
Approximately 5 minutes
Sri Lanka Medical Device Labeling: NMRA Requirements and Trilingual IFU for Patients
Medical devices registered with the NMRA in Sri Lanka must include primary and secondary labels containing the approved name, manufacturer details, and traceability information (lot/batch, dates). Crucially, patient information leaflets for household-use devices (e.g., glucometers) must be provided in **English, Sinhala, and Tamil** to ensure accessibility across the country.